Paul Goepfert, MD
Infectious Disease · Birmingham, ALNPI 1366470718
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,625 of the $5,625 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Janssen Scientific Affairs, LLC.
Across 3 payments — averaging $1875.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Scientific Affairs, LLC$6K
Across 16 payments — averaging $25,191 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$386K
- Pfizer$12K
- Janssen Research & Development, LLC$5K
What the payments were for
- Consulting fees$5,625100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Scientific Affairs, LLC | 3 | $5,625 |
How this compares
$5,625 in reported general payments places this provider in the 70th percentile of 104 infectious disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 32 | $118,092 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $391 |
| Gabapentin | 53 | $328 |
| Amlodipine Besylate | 21 | $109 |
| Oxycodone Hcl | 11 | $105 |
| Atorvastatin Calcium | 13 | $57 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Birmingham
- John BaddleyBirmingham$113K
- Christina MuznyBirmingham$111K
- Sonya HeathBirmingham$80K
- William GeislerBirmingham$63K
- Edward HookBirmingham$61K
- Edgar OvertonBirmingham$46K
- Jane SchwebkeBirmingham$42K
- Peter PappasBirmingham$25K
- Jeanne MarrazzoBirmingham$23K
- Todd McCartyBirmingham$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.